Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Classement en actions
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Prix de l'action
$8.03
Capitalisation boursière
$6.31B
Changement (1 jour)
1.07%
Changement (1 an)
-8.04%
Pays
CN
Échange Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Catégorie
Healthcare
Historique du rendement du dividende pour Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Le rendement du dividende (TTM) de Shenzhen New Industries Biomedical Engineering Co., Ltd. (symbole boursier : 300832) au 2024-12-31 est : 1.41%
Rendement moyen du dividende sur les 5 dernières années : 1.40%
Rendement moyen du dividende sur les 5 dernières années : 1.40%
Historique du rendement du dividende de Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) de 2012 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 2.24% | -3.03% |
| 2025 | 2.31% | 63.83% |
| 2024 | 1.41% | 56.67% |
| 2023 | 0.90% | -25.00% |
| 2022 | 1.20% | 0.84% |
| 2021 | 1.19% | 4.39% |
| 2020 | 1.14% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.60% | -45.95% |
| 2017 | 1.11% | 236.36% |
| 2016 | 0.33% | 26.92% |
| 2015 | 0.26% | 85.71% |
| 2014 | 0.14% | 100.00% |
| 2013 | 0.07% | 16.67% |
| 2012 | 0.06% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 2.51% |
US
|
|
| 3.02% |
IE
|
|
| 1.14% |
US
|
|
| 0.00% |
US
|
|
| 2.39% |
DE
|
